老年心脏病学杂志（英文版）2026，Vol.23Issue(2)：83-99,17.DOI:10.26599/1671-5411.2026.02.001
Semaglutide ameliorates coronary microembolization-induced injury by suppressing apoptosis and inflammation via the HM-GB1/RAGE/NF-κB p65 pathway
Semaglutide ameliorates coronary microembolization-induced injury by suppressing apoptosis and inflammation via the HM-GB1/RAGE/NF-κB p65 pathway
Hua-Feng YANG 1Hong-Qing LI 2Qiang WANG 2Xian-Tao WANG 2Lang LI2
作者信息
- 1. Cardiac Surgery Intensive Care Unit,The First Affiliated Hospital of Guangxi Medical University,Nanning,China
- 2. De-partment of Cardiology,The First Affiliated Hospital of Guangxi Medical University,Nanning,China
- 折叠
引用本文复制引用
Hua-Feng YANG,Hong-Qing LI,Qiang WANG,Xian-Tao WANG,Lang LI..Semaglutide ameliorates coronary microembolization-induced injury by suppressing apoptosis and inflammation via the HM-GB1/RAGE/NF-κB p65 pathway[J].老年心脏病学杂志（英文版）,2026,23(2):83-99,17.
